All posts by Sandrine Lemouton

April 23- 25, 2017
Chicago, IL – USA
Booth #313-315

We will present and demonstrate our wide range of preclinical instruments for neuro, pulmonary and cardio studies.

This year, a special focus is done on sleep studies with whole body plethysmography, and easy integration with cardio and neuro parameters.

>Visit our blog to learn more !

Event website: http://experimentalbiology.org/2017/Home.aspx

How to find us?

April 21- 23, 2017
Tokyo – JAPAN
Booth #48

Join us at the 57th Annual Meeting of the Japanese Respiratory Society (JRS) in Tokyo.

We will be happy to discuss new lung volume measurement capabilities for the flexiVent, and how translational lung volume measurements (TLC, FRC, RV) add new insights for research in COPD, pulmonary fibrosis, acute lung injury, sepsis, aging, and other areas of lung research.

The flexiVent is recognized as the gold-standard for the measurements of lung function in laboratory animals. Using the forced oscillation technique (FOT), it permits a detailed study of the lungs via:

  • Airway hyper-responsiveness studies (AHR)
  • Respiratory mechanics (lung resistance, lung compliance, central vs. peripheral airway effects)
  • Spirometry/FEV
  • Lung volumes *new*

To learn more: Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique

If you do not plan to attend JRS, but are interested in more information about our products, please contact our office in Kobe.

 

Evaluation of Ketamine to Reduce Semi-Acute Electrophysiological and Behavioral Compromise following Nerve Agent Exposure

 

Dr. Waylon Weber, Ph.D. Research Scientist at Lovelace biomedical, will explain how his company uses emka TECHNOLOGIES’s rodentPACK along with IOX2 and ecgAUTO software, to perform the evaluation of Ketamine to Reduce Semi-Acute Electrophysiological and Behavioral Compromise following Nerve Agent Exposure.

Platform Session Title: Chemical and Biological Weapons

Session Time: Tuesday March 14, 2017 – 9:30 AM – 12:15 PM

Presentation Time: 3/14/2017 9:50:00 AM

Abstract Title: Evaluation of Ketamine to Reduce Semi-Acute Electrophysiological and Behavioral Compromise following Nerve Agent Exposure

Abstract Number: 1625

Where? Baltimore Convention Center – Room 314
1 W Pratt St. Baltimore MD 21201

See the SOT website.

Descriptif du poste

A l’interface entre la physique, l’électronique et le monde médical, votre principale mission sera de concevoir et de développer des chaînes d’acquisitions analogiques et numériques optimisées et de les interfacer avec la couche de communication sans fil :

  • Veille technologique et scientifique sur les capteurs physiologiques et la communication sans fil
  • Détection/conception des solutions électroniques adaptées aux contraintes de faible coût, faible consommation, faible encombrement, et d’industrialisation
  • Développement de cartes prototypes et layout associé
  • Développement du logiciel embarqué associé
  • Mise en place d’expérimentation (instrumentation)/tests/validations

Profil recherché                   

Diplômé d’une Grande Ecole d’Ingénieur ou équivalent, profil physicien ou électronicien, vous êtes passionné de nouvelles technologies, vous êtes attiré par le risque et l’innovation. Un goût pour l’électronique analogique, l’expérimentation et l’instrumentation est indispensable. La maîtrise de la programmation en C/C++ sur microcontrôleur et des connaissances en hyperfréquence seraient un plus. Le poste est ouvert aux ingénieurs débutants ou ayant une première expérience et motivés par la R&D.

Un bon niveau d’anglais est requis.

Rémunération :  incluant une part variable compris entre 45 et 55 k€ selon expérience.

Pourquoi nous rejoindre

  • L’opportunité de s’investir dans une société française avec une réelle reconnaissance internationale,
  • La possibilité de travailler avec des équipes dynamiques et pluridisciplinaires et de s’investir sur un poste couvrant des responsabilités allant de la R&D à l’industrialisation,
  • La fierté de participer à la création de nouveaux objets connectés « santé »,
  • Un poste vous permettant d’être au contact des grands acteurs mondiaux de la pharmacologie,
  • Un poste dans lequel vous pourrez exprimerez votre créativité, votre potentiel et grandirez rapidement

Type de contrat

CDI.

Comment postuler

Envoyez vos CV et lettre de motivation à  emka@emka.fr             

July 3-6, 2016
Châtenay-Malabry – France

Join us at the 12th meeting “New Frontiers in Basic Cardiovascular Research: France – New EU members” that will be held in Châtenay-Malabry (close to Paris), at the Faculty of Pharmacy of the University Paris-Sud.

The scientific program will specifically focus on :

  • Vascular pathophysiology
  • Cardiovascular metabolism
  • Signaling in the normal and pathologic heart
  • Rhythm and arrhythmias
  • Ionic channels modulation
  • Excitation-contraction coupling and calcium handling
  • Cardioprotection

We will be happy to demonstrate our cardiovascular solutions at the booth, and especially:

June 15-17, 2016
Davis, CA, USA
Event website: www.ninds.nih.gov/research/counterterrorism/counterACT

This event is dedicated to the discovery and identification of therapeutic countermeasures against agents such as chlorine, sarin gas, organophosphates, and other chemical threats. Join us to discuss your research projects, and come see the latest innovations with our physiology research instruments.

Five good reasons, supported by recent scientific articles, to visit us at CounterACT this year:

  1. Monitor onset fever, body temperature, blood pressure and other outcomes wirelessly using our new easyTEL implanted telemetry biodefense solutions.
  2. Measure detailed lung function and airway hyper-responsiveness in vivo using the flexiVent. Quantify disease progression and evaluate novel treatments against airborne threats such as sarin, chlorine, sulfur mustard gas, and other chemical agents. See recent publication by Wigenstam et al.
  3. Develop precise aerosol exposure models through the use of accumulated volumes (AV) analyzers for large animals (Plethysmography, RIP) and inhalation exposure solutions for small rodents (inExpose). Here is a recent example by Humberd Smith et al. using an influenza ferret model.
  4. Monitor cardiovascular outcomes (Heart rate variability, QT prolongation, etc.) to ascertain cardiotoxic effects following exposures to Sarin and other toxins, as recently shown by Saxena et al.
  5. Evaluate seizure liability and EEG following exposures to toxins or therapeutic interventions, as recently published by Esneault et al.

Our solutions cover a wide range of pulmonary, cardio, and neuro research applications, from the comprehensive study of vesicant induce lung injury or cardio toxicity to the development and validation of novel therapeutics approaches. We will be happy to demonstrate these and other pre-clinical solutions at the booth.